A Phase II study of M605110 for axillary osmidrosis

A Phase II, placebo-controlled, randomized, double-blind, parallel-group, multicenter study to evaluate efficacy and safety of M605110 in patients with axillary osmidrosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2031220072

Enrollment

105

Registered

2022-05-19

Start date

2022-05-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

axillary osmidrosis

Interventions

Apply an appropriate amount on axilla

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with axillary osmidrosis 15 years old and over

Exclusion criteria

Exclusion criteria: (1)Not suitable for application of investigational drug from the viewpoint of safety, such as a wound on the axilla, or patients with complications or abnormal findings on the axilla affecting safety assessment. (2)Patients judged by the investigator or sub-investigator to have a degree of odor(other than axillary odor) that may affect the evaluation of axillary odor.

Design outcomes

Primary

Measure	Time frame
axillary odor scores, NRS	—

Contacts

Public Contact- Clinical Trials Information

Maruho Co.,Ltd. Kyoto R&D Center

ctinfo@mii.maruho.co.jp+81-75-325-3279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026